Skip to Content


In the US, Mesna (mesna systemic) is a member of the drug class antineoplastic detoxifying agents and is used to treat Hemorrhagic Cystitis Prophylaxis.

US matches:

UK matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories

Mucolytic agent

Detoxifying agent for antineoplastic treatment (urotoxicity of oxazaphosphorine)

Chemical Name

Etanesulfonic acid, 2-mercapto-, monosodium salt

Foreign Names

  • Mesnum (Latin)
  • Mesna (German)
  • Mesna (French)
  • Mesna (Spanish)

Generic Names

  • Mesna (OS: USAN, DCIT, DCF, BAN, JAN)
  • Asta D 7093 (IS: Asta)
  • Sodium 2-mercaptoethanesulfonate (IS: WHO)
  • UCB 3983 (IS: UCB)
  • Mesna (PH: BP 2016, Ph. Eur. 8, USP 38)
  • Mesnum (PH: Ph. Eur. 8)

Brand Names

  • Holoxan-Uromitexan (Mesna and Ifosfamide)
    Zydus, India
  • Ifoxan with Mesna (Mesna and Ifosfamide)
    Alkem, India
  • Medaltec
    Tecnofarma, Mexico
  • Mei An
    Hengrui, China
  • Mesa
    Nang Kuang, Taiwan
  • Mescryo
    Cryopharma, Mexico
  • Mesna Baxter
    Baxter, Malta; Baxter Healthcare, United States; Baxter Oncology, United Kingdom
  • Mesna Delta
    Delta Farma, Argentina
  • Mesna EG
    EG Labo, France
  • Mesna Filaxis
    Filaxis, Argentina
  • Mesna Gobbi
    Gobbi-Novag, Argentina
  • Mesna Microsules
    Microsules Arg, Argentina
  • Mesna Norgreen
    Norgreen, Argentina
  • Mesna Techno
    Techno, Bangladesh
  • Mesna Teva
    Laboratorio Chile, Chile
    Sanolabor, Slovenia
  • Mesnex
    Baxter Healthcare, United States
  • Mestian
    LKM, Argentina
  • Mistabron
    AHN Pharma, South Africa; UCB, Taiwan
  • Mitexan
    ASTA Medica, Brazil
  • Mucofluid
    UCB, Poland; UCB Pharma, Spain
  • Novacarel
    Pisa, Mexico
  • Siruta
    Taiwan Biotech, Taiwan
  • Uromes
    Korea United Pharm, Georgia; Sanfer, Mexico
  • Uromitexan
    Agmar, Croatia (Hrvatska); ASTA Medica, Lebanon; Baxter, Australia; Baxter, Bosnia & Herzegowina; Baxter, Belgium; Baxter, Bulgaria; Baxter, Canada; Baxter, Switzerland; Baxter, Chile; Baxter, China; Baxter, Denmark; Baxter, Ecuador; Baxter, Egypt; Baxter, Spain; Baxter, Finland; Baxter, France; Baxter, Georgia; Baxter, Greece; Baxter, Hong Kong; Baxter, Hungary; Baxter, Iceland; Baxter, Lithuania; Baxter, Latvia; Baxter, Netherlands; Baxter, Norway; Baxter, New Zealand; Baxter, Oman; Baxter, Poland; Baxter, Portugal; Baxter, Romania; Baxter, Sweden; Baxter, Slovakia; Baxter, Thailand; Baxter, Tunisia; Baxter, Taiwan; Baxter Healthcare, Austria; Baxter Oncology, Czech Republic; Baxter Oncology, Germany; Baxter Oncology, Estonia; Baxter Oncology, Singapore; Baxter-RM, Italy; Eczacibasi Baxter, Turkey; Sanofi-Aventis, Bangladesh; Sanofi-Aventis, South Africa; Shionogi Seiyaku, Japan; Transfarma Medica Indah, Indonesia; Zydus, India
  • Varimesna
    Varifarma, Argentina


BANBritish Approved Name
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.